What Happened?
New York, NY-based Phosplatin-Therapeutics Appointed Robert Fallon as President and Chief Executive Officer
About the Company
Phosplatin Therapeutics is a private, clinical stage biopharmaceutical company founded in 2010, and funded by private investors and family investment offices in the U.S., Europe and Asia.
About the Person
Robert Fallon is President and Chief Executive Officer at Phosplatin Therapeutics. Previously, Robert held various senior HR leadership roles in the industry.
Info Source
News
Short Profile